Description
Human Recombinant AKR1C3 is available at Gentaur for Next week delivery.
Involved in in the detoxification of aldehydes and ketones
Biomolecule/Target:
Alternates names: Aldo-keto reductase family 1, member C 3, DD3, DDX, HA1753, HAKRB, HAKRe, hluPGFS, HSD17B5.
Synonyms: Human Recombinant AKR1C3
Background Information: Aldo-keto reductase family 1 member C3 in humans is encoded by the AKR1C3 gene. This enzyme catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ), and the oxidation of 9alpha, 11beta-PGF2 to PGD2. It may play an important role in the pathogenesis of allergic diseases such as asthma, and may also have a role in controlling cell growth and/or differentiation.
Reconstitution Instructions: N/A
NCBI Gene Symbol: AKR1C3
Gene ID: 8644
NCBI Accession: P42330
Additional Information
Size: |
1 mg |
Country of Manufacturing Origin: |
USA |
Country of Animal Origin: |
USA |
Gene Source: |
Human |
Recombinant: |
Yes |
Source: |
E. coli |
Purity by SDS-PAGE: |
≥98% |
Assay: |
SDS-PAGE |
Purity: |
N/A |
Assay 2: |
N/A |
Endotoxin Level: |
< 1.0 EU per 1 μg of protein (determined by LAL method). |
Activity (Specifications/test method): |
N/A |
Biological activity: |
The specific activity of AKR1C3 with 5 mM 1-Indanol is approximately 0.3 U/mg. |
Molecular Weight: |
39 kDa |
Storage Temperature: |
-20°C |
Shelf Life: |
12 months |
Concentration: |
1 mg/ml |
Appearance: |
Liquid |
Handling: |
Centrifuge the vial prior to opening. |